Faculty Opinions recommendation of A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
2021 ◽
Vol Publish Ahead of Print
◽
2011 ◽
Vol 10
(7)
◽
pp. 618-625
◽